09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, 20<strong>09</strong>, 9, 3373 – 3601 3425<br />
A61P 1/16 (2006.01)<br />
C07D 207/44 (2006.01)<br />
(86) PCT/EP2007008238 21.<strong>09</strong>.2007.<br />
(96) EP 07818328.2 21.<strong>09</strong>.2007.<br />
(87) WO2008067863, 12.06.2008. 200824<br />
(97) EP 2<strong>09</strong>1531, 26.08.20<strong>09</strong>. 20<strong>09</strong>35, En<br />
(31) 06022194 (32) 24.10.2006. (33) EP<br />
(54) PHENYL SUBSTITUTED MALEIMIDES AS MEDICAMENTS FOR<br />
BLOCKING DEGENERATIVE TISSUE DAMAGES BY INHIBITING<br />
MPT<br />
(71) Congenia S.r.l., Piazzetta Bossi 4, 20121 Milano, IT<br />
(72) PELICCI, PierGiuseppe, Via Emilia, 10, I-20<strong>09</strong>0 Opera, IT<br />
GIORGIO, Marco, Via Trieste, 4/c, I-27010 San Genesio, IT<br />
MINUCCI, Saverio, Via Sporting Mirasole, 23, I-20<strong>09</strong>0 Noverasco<br />
Opera, IT<br />
BERNARDI, Paolo, Department of Biomedical Sciences University<br />
of Padova Viale Colombo, 3, I-35121 Padova, IT<br />
PAIN, Gilles, Via de Gasperi 39, I-04021 Castelforte, IT<br />
COURTNEY, Stephen, Martin, Evotec (UK) Ltd 114 Milton Park<br />
Abingdon, Oxfordshire OX14 4SA, GB<br />
YARNOLD, Christopher John, Evotec (UK) Ltd 114 Milton Park<br />
Abington, Oxfordshire OX11 8ST, GB<br />
KRAEMER, Joachim, Evotec AG Schnackenburgallee 114, 22525<br />
Hamburg, DE<br />
(51) MKP<br />
A61K 31/403 (2006.01) (97) EP 2<strong>09</strong>7079 *<br />
A61K 31/407 (2006.01)<br />
A61K 31/437 (2006.01)<br />
A61K 31/57 (2006.01)<br />
A61K 31/566 (2006.01)<br />
A61K 31/568 (2006.01)<br />
A61K 31/5685 (2006.01)<br />
A61P 1/00 (2006.01)<br />
A61P 3/10 (2006.01)<br />
A61P 9/00 (2006.01)<br />
A61P 11/06 (2006.01)<br />
A61P 17/02 (2006.01)<br />
A61P 25/02 (2006.01)<br />
A61P 25/28 (2006.01)<br />
A61P 29/00 (2006.01)<br />
(86) PCT/GB2007004584 29.11.2007.<br />
(96) EP 07870407.9 29.11.2007.<br />
(87) WO2008065408, 05.06.2008. 200823<br />
(97) EP 2<strong>09</strong>7079, <strong>09</strong>.<strong>09</strong>.20<strong>09</strong>. 20<strong>09</strong>37, En<br />
(31) 0623971 (32) 30.11.2006. (33) GB<br />
867873 P 30.11.2006. US<br />
(54) MODULATION OF PROSTAGLANDIN/CYCLOOXYGENASE<br />
METABOLIC PATHWAYS<br />
(71) Hunter-Fleming Limited, Regus House, 1 Friary, Temple Quay,<br />
Bristol BS1 6EA, GB<br />
(72) WüLFERT, Ernst, Avenue des Aubepines 52, 1180 Brussels, BE<br />
(51) MKP<br />
A61K 31/4045 (2006.01) (97) EP 2<strong>09</strong>9451 *<br />
A61K 31/53 (2006.01)<br />
A61K 45/06 (2006.01)<br />
A61P 35/02 (2006.01)<br />
(86) PCT/US2007024712 30.11.2007.<br />
(96) EP 07862420.2 30.11.2007.<br />
(87) WO2008070011, 12.06.2008. 200824<br />
(97) EP 2<strong>09</strong>9451, 16.<strong>09</strong>.20<strong>09</strong>. 20<strong>09</strong>38, En<br />
(31) 868388 P (32) 04.12.2006. (33) US<br />
(54) COMBINATION OF AN HDAC INHIBITOR AND AN<br />
ANTIMETABOLITE<br />
(71) Novartis AG, Lichtstrasse 35, 4056 Basel, CH<br />
(72) ATADJA, Peter Wisdom, 9 Reeve Street, Acton, Massachusetts<br />
01720, US<br />
(51) MKP<br />
A61K 31/407 (2006.01) (97) EP 2089020 *<br />
C07D 487/04 (2006.01)<br />
C07D 498/04 (2006.01)<br />
A61P 31/12 (2006.01)<br />
(86) PCT/US2007084777 15.11.2007.<br />
(96) EP 07864430.9 15.11.2007.<br />
(87) WO2008064057, 29.05.2008. 200822<br />
(97) EP 2089020, 19.08.20<strong>09</strong>. 20<strong>09</strong>34, En<br />
(31) 866120 P (32) 16.11.2006. (33) US<br />
939753 14.11.2007. US<br />
(54) MACROCYCLIC PEPTIDES AS HEPATITIS C VIRUS<br />
INHIBITORS<br />
(71) Bristol-Myers Squibb Company, Route 206 and Province Line<br />
Road, Princeton, NJ 08543-4000, US<br />
(72) WANG, Alan Xiangdong, Bristol-Myers Squibb Company 5<br />
Research Parkway, Wallingford, CT 06492, US<br />
ZHENG, Barbara Zhizhen, Bristol-Myers Squibb Company 5<br />
Research Parkway, Wallingford, CT 06492, US<br />
D'ANDREA, Stanley, Bristol-Myers Squibb Company 5 Research<br />
Parkway, Wallingford, CT 06492, US<br />
MEANWELL, Nicholas A., Bristol-Myers Squibb Company 5<br />
Research Parkway, Wallingford, CT 06492, US<br />
SCOLA, Paul Michael, Bristol-Myers Squibb Company 5 Research<br />
Parkway, Wallingford, CT 06492, US<br />
(51) MKP<br />
A61K 31/41 (2006.01) (97) EP 2086535 *<br />
A61K 31/4184 (2006.01)<br />
A61P 9/00 (2006.01)<br />
A61P 13/12 (2006.01)<br />
A61K 45/06 (2006.01)<br />
(86) PCT/EP2007060531 04.10.2007.<br />
(96) EP 0782<strong>09</strong>08.7 04.10.2007.<br />
(87) WO2008040774, 10.04.2008. 200815<br />
(97) EP 2086535, 12.08.20<strong>09</strong>. 20<strong>09</strong>33, En<br />
(31) 06121905 (32) 06.10.2006. (33) EP<br />
(54) ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE<br />
TREATMENT OF SYSTEMIC DISEASES IN CATS<br />
(71) BOEHRINGER INGELHEIM VETMEDICA GMBH, Binger Strasse<br />
173, 55218 Ingelheim am Rhein, DE<br />
(72) STARK, Marcus, Brueder-Grimm-Str. 43, 55218 Ingelheim, DE<br />
SENT, Ulrike, Ernst Barlach Str. 5, 65195 Wiesbaden, DE<br />
LANG, Ingo, An der Selzer Muehle 40a, 55218 Ingelheim Am<br />
Rhein, DE<br />
(51) MKP<br />
A61K 31/4188 (2006.01) (97) EP 2<strong>09</strong>4265 *<br />
A61P 39/00 (2006.01)<br />
A61P 25/02 (2006.01)<br />
(86) PCT/EP2007062323 14.11.2007.<br />
(96) EP 07847162.0 14.11.2007.<br />
(87) WO2008058988, 22.05.2008. 200821<br />
(97) EP 2<strong>09</strong>4265, 02.<strong>09</strong>.20<strong>09</strong>. 20<strong>09</strong>36, En<br />
(31) 06124142 (32) 15.11.2006. (33) EP<br />
(54) PYRROLOY[1,2-A]IMIDAZOLEDIONE EFFECTIVE IN THE<br />
TREATMENT OF PERIPHERAL NEUROTOXICITY INDUCED BY<br />
CHEMOTHERAPEUTIC AGENTS<br />
(71) Neurotune AG, Wagistrasse 27a, 8952 Schlieren, CH<br />
(72) FARINA, Carlo, Via Mario Donati 8, 20146 Milano, IT<br />
GHELARDINI, Carla, Via Bastianaccio 21, 55100 Pistoia, IT<br />
PETRILLO, Paola, Via Cimabue 9, 20148 Milano, IT<br />
(51) MKP<br />
A61K 31/427 (2006.01) (97) EP 2089024 *<br />
A61K 31/437 (2006.01)<br />
A61K 31/553 (2006.01)<br />
A61K 31/704 (2006.01)<br />
A61K 31/7068 (2006.01)<br />
A61P 35/00 (2006.01)<br />
(86) PCT/US2007085579 27.11.2007.<br />
(96) EP 07868853.8 27.11.2007.<br />
(87) WO2008067280, 05.06.2008. 200823<br />
(97) EP 2089024, 19.08.20<strong>09</strong>. 20<strong>09</strong>34, En<br />
(31) 867448 P (32) 28.11.2006. (33) US<br />
891088 P 22.02.2007. US<br />
(54) COMBINATION OF IAP INHIBITORS AND FLT3 INHIBITORS<br />
(71) Novartis AG, Lichtstrasse 35, 4056 Basel, CH<br />
Dana-Farber Cancer Institute, Inc., 44 Binney Street, Boston, MA<br />
02115, US<br />
(72) GRIFFIN, James Douglas, 156 Dean Road, Brookline,<br />
Massachusetts 02445, US<br />
ZAWEL, Leigh, 13 Patriots Way, Hingham, Massachusetts 02043,<br />
US<br />
ISSN 1331-2030